Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Completed × Electrochemotherapy × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Liver Metastases 1

Interventions

Cyclophosphamide 111 Gemcitabine 104 Paclitaxel 103 Radiotherapy 96 Carboplatin 91 pembrolizumab 90 Cisplatin 86 Nivolumab 78 Docetaxel 77 Rituximab 68 Lenalidomide 62 Cytarabine 54 Bevacizumab 54 Peripheral Blood Stem Cell Transplantation 53 Etoposide 53 Dexamethasone 52 Filgrastim 51 fludarabine phosphate 50 Fluorouracil 50 Capecitabine 50 Temozolomide 49 Oxaliplatin 46 Doxorubicin 45 Prednisone 44 Irinotecan 44 Everolimus 44 Cetuximab 43 Melphalan 42 Erlotinib Hydrochloride 42 Sorafenib 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01264952 2020-11-24

ECTJ

Institute of Oncology Ljubljana

Phase 1/2 Completed

16 enrolled 9 charts

Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡